Larisa Geskin, MD of Columbia University Medical Center, New York, NY summarizes her views on the developments and upcoming meetings in cutaneous T-cell lymphoma (CTCL) at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the European Association of Dermato-Oncology (EADO) in Vienna, Austria. According to Dr Geskin, we are living in exciting times as many new drugs and approaches are coming to CTCL therapy. Further, there are meetings coming up, including the World Congress in Cutaneous Lymphomas in October at Columbia University where these new development will be highlighted.
What’s next for cutaneous T-cell lymphoma and World Congress in Cutaneous Lymphomas
